XML 32 R22.htm IDEA: XBRL DOCUMENT v3.25.0.1
Stock-Based Compensation (Tables)
 9 Months Ended
Dec. 31, 2024
Stock-Based Compensation [Abstract]  
Schedule of Assumptions were used in the Fair-Value Method The following assumptions were used in the fair-value method calculations:
   

Three Months Ended

December 31,

     Nine Months Ended
December 31,		  
    2024     2023     2024     2023  
Risk-free interest rates     3.9% - 4.4%       3.8% - 4.7%       3.5% - 4.4%       3.5% - 4.7%  
Volatility     110% - 113%       123.4% - 127.6%       110% - 123%       82.5% - 152.2%  
Expected life (years)     5.0 – 5.7       5.0 – 5.4       5.0 – 5.7       5.0 – 6.2  
Schedule of Activity in the Shares

The following table summarizes the activity in the shares available for grant under the Plan during the nine months ended December 31, 2024:

 

       Options Outstanding 
           Weighted 
   Shares       Average 
   Available   Number of   Exercise 
   for Grant   Shares   Price ($) 
Balance at March 31, 2024   3,648,651    3,689,341    3.70 
Share awards   (3,875)   
—
    1.56 
Options granted   (682,375)   682,375    1.52 
Options exercised   
—
    (7,530)   1.08 
Options cancelled and returned to the Plan   42,230    (42,230)   2.62 
Balance at June 30, 2024   3,004,631    4,321,956    3.36 
Share awards   (3,875)   
—
    2.28 
Options granted   (483,673)   483,673    1.81 
Options cancelled and returned to the Plan   274,901    (274,901)   1.51 
Balance at September 30, 2024   2,791,984    4,530,728    3.33 
Share awards   (3,875)   
—
    1.37 
Options granted   (129,375)   129,375    1.88 
Options cancelled and returned to the Plan   27,388    (27,388)   1.30 
Balance at December 31, 2024   2,686,122    4,632,715    3.30 
Schedule of RSU Activity under the Plan

A summary of restricted stock unit (“RSU”) activity under the Plan is presented below.

 

       Weighted
Average		 
   Number of
Shares		   Grant-Date
Fair Value
($)		 
Non-vested shares at March 31, 2024   187,499    0.91 
Vested   (20,832)   0.91 
Non-vested shares at June 30, 2024   166,667    0.91 
Vested   (20,833)   0.91 
Non-vested shares at September 30, 2024   145,834    0.91 
Vested   (20,833)   0.91 
Non-vested shares at December 31, 2024   125,001    0.91 
Schedule of Outstanding and Exercisable Options

The following table summarizes the range of outstanding and exercisable options as of December 31, 2024:

 

   Options Outstanding   Options Exercisable 
Range of Exercise Price  Number
Outstanding		   Weighted
Average
Remaining
Contractual
Life
(in Years)		   Weighted
Average
Exercise
Price ($)		   Number
Exercisable		   Weighted
Average
Exercise
Price ($)		   Aggregate
Intrinsic
value ($)		 
$0.93 - $2.28   3,200,441    8.22    1.59    2,095,570    1.57    213,512 
$3.95 - $7.51   933,145    6.43    5.30    873,089    5.37    
—
 
$8.61 - $17.70   499,129    6.48    10.56    499,129    10.56    
—
 
$0.93 - $17.70   4,632,715    7.67    3.30    3,467,788    3.82    213,512